Skip to main content
. 2017;18(4):1007–1013. doi: 10.22034/APJCP.2017.18.4.1007

Table 1.

Patient’s Characteristics

PSA concentration PSA ≤ 10 ng/ml 10 ng/ml> PSA <20 ng/ml
302 98
Gleason score 2 3 4 5 6 7
4 2 25 84 223 62
TNM stage T1c T2a T2b T2c
218 107 49 26
Risk group LR LR
ADT (-) (+) (-) (+)
(before SABR) 95 119 72 114

PSA, Prostate Specific Antigen; TNM, Tumor, Nodes, Metastases; ADT, Androgen Deprivation Therapy; SABR, Stereotactic Ablative Radiotherapy